Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Cirrhosis 1Hepatitis, Alcoholic 1Hepatitis D 1Carcinoma, Hepatocellular 1Acquired Immunodeficiency Syndrome 1

Interventions

Tobacco Use Cessation Devices 2Surveys and Questionnaires 2Nivolumab 2Human Papillomavirus Recombinant Vaccine nonavalent 2Electrocoagulation 2Biopsy 2fludarabine phosphate 1fludarabine 1Watchful Waiting 1Trichloroacetic Acid 1Transurethral Resection of Prostate 1Tomography, X-Ray Computed 1Thiotepa 1Therapeutics 1Tacrolimus 1Self Care 1Ritonavir 1Registries 1Rapid Diagnostic Tests 1Proctoscopy 1Papillomavirus Vaccines 1Occult Blood 1Observation 1Nevirapine 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Melphalan 1Mass Screening 1Mammography 1Lopinavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Acquired Immunodeficiency Syndrome × Anti-HIV Agents × Clear all
NCT02344680 2025-06-10

Liver Fibrosis in Zambian HIV-HBV Co-infected Patients

University of Alabama at Birmingham

Active not recruiting
303 enrolled
Gastrointestinal

Acquired Immunodeficiency Syndrome, Hepatitis D, Hepatitis, Alcoholic, Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡